Model DetailsLung tumor
Model Name |
Lung tumor | Strain |
A/J |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
pulmonary tumor • lung tumor • primary lung tumor |
Strain Synonyms |
A • A/J-Jax • Strain A • A/J, H-2a • A/Lilly • A/Jax • AJ • strain A • A/Cloudman |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Lung | Male |
6% |
|
Smith GS, J Natl Cancer Inst 1973 May;50(5):1195-213 | |
| Lung | Female |
14% |
|
Smith GS, J Natl Cancer Inst 1973 May;50(5):1195-213 | |
| Lung | Male |
64% (7 of 11 mice) |
~65 weeks |
|
Groch KM, Int J Radiat Biol 1997 Mar;71(3):301-8 |
| Lung | Male |
8.3% (2 of 24 mice) |
6.5-7 months |
|
Witschi H, Carcinogenesis 1997 Mar;18(3):575-86 |
| Lung | Male |
37.5% (9 of 24 mice) |
10.5-11 months |
|
Witschi H, Carcinogenesis 1997 Mar;18(3):575-86 |
| Lung | Male |
56% (23 of 41 mice) |
10.5-11 months |
|
Witschi H, Carcinogenesis 1997 Mar;18(3):575-86 |
| Lung | Male |
57% (13 of 23 mice) |
10.5-11 months |
|
Witschi H, Carcinogenesis 1997 Mar;18(3):575-86 |
| Lung | Female |
41% |
|
Staats J, Companion to Mouse News Lett No. 21 1959;(): | |
| Lung | Male |
49% |
|
Staats J, Companion to Mouse News Lett No. 21 1959;(): | |
| Lung | Female |
40% |
|
Staats J, Companion to Mouse News Lett No. 25 1961;(): | |
| Lung | Male |
50% |
|
Staats J, Companion to Mouse News Lett No. 25 1961;(): | |
| Lung | Mixed Population |
23 to 59 |
|
Russell ES, 1966;():511-519 | |
| Lung | Female |
32% |
|
Hoag WG, Ann N Y Acad Sci 1963 Nov 4;108():805-831 | |
| Lung | Female |
26% |
|
Hoag WG, Ann N Y Acad Sci 1963 Nov 4;108():805-831 | |
| Lung | Male |
6% |
|
Hoag WG, Ann N Y Acad Sci 1963 Nov 4;108():805-831 | |
| Lung | Male |
6% |
|
Festing MFW, Mouse Genome 1996;94(3):523-677 | |
| Lung | Female |
32% |
|
Festing MFW, Mouse Genome 1996;94(3):523-677 | |
| Lung | Female |
26% |
|
Festing MFW, Mouse Genome 1996;94(3):523-677 | |
| Lung | Unspecified |
90% |
18 months |
|
You M, Proc Natl Acad Sci U S A 1992 Jul 1;89(13):5804-8 |
| Lung | Female |
33% (3 of 9 mice) |
10 months |
|
D'Agostini F, Int J Oncol 2001 Mar;18(3):607-15 |
| Lung | Female |
0% (0 of 1 mice) |
6 months |
|
D'Agostini F, Int J Oncol 2001 Mar;18(3):607-15 |
| Lung | Unspecified |
90% |
18 months |
|
Ryan J, J Natl Cancer Inst 1987 Dec;79(6):1351-7 |
| Lung | Unspecified |
observed |
|
Devereux TR, Mol Carcinog 1993;8(3):177-85 | |
| Lung | Male |
0% (0 of 10 mice) |
2 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
0% (0 of 10 mice) |
3 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
0% (0 of 20 mice) |
4 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
0% (0 of 20 mice) |
5 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
0% (0 of 20 mice) |
6 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
5% (1 of 20 mice) |
7 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
12% (4 of 34 mice) |
8 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
18% (8 of 44 mice) |
9 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
44% (17 of 39 mice) |
10 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
40% (22 of 55 mice) |
11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
39% (27 of 70 mice) |
12 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
57% (29 of 51 mice) |
13 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
43% (33 of 76 mice) |
14 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
59% (29 of 49 mice) |
15 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
67% (29 of 43 mice) |
16 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
62.5% (20 of 32 mice) |
17 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
73% (36 of 49 mice) |
18 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
81% (38 of 47 mice) |
19 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
78% (18 of 23 mice) |
20 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
37% (58 of 157 mice) |
10-11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
43% (74 of 173 mice) |
10-11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
36% (20 of 55 mice) |
10-11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
0% (0 of 10 mice) |
2 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
0% (0 of 10 mice) |
3 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
4.8% (1 of 21 mice) |
4 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
0% (0 of 20 mice) |
5 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
5% (1 of 20 mice) |
6 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
5% (1 of 20 mice) |
7 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
7.3% (3 of 41 mice) |
8 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
21% (7 of 34 mice) |
9 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
23% (29 of 128 mice) |
10 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
37% (19 of 51 mice) |
11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
36% (27 of 76 mice) |
12 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
40% (21 of 53 mice) |
13 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
45% (25 of 56 mice) |
14 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
53% (27 of 51 mice) |
15 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
61% (11 of 18 mice) |
17 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
65% (24 of 37 mice) |
18 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
67% (12 of 18 mice) |
19 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
75% (15 of 20 mice) |
20 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
27% (49 of 182 mice) |
10-11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
32% (50 of 157 mice) |
10-11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
32% (17 of 53 mice) |
10-11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
17% (3 of 18 mice) |
7-8 months after treatment |
|
Gray DL, Exp Lung Res 2001 Apr-May;27(3):245-53 |
| Lung | Female |
58% (7 of 12 mice) |
19-20 weeks |
|
Gunning WT, Exp Lung Res 2000 Dec;26(8):757-72 |
| Lung | Female |
100% (10 of 10 mice) |
32-33 weeks |
|
Gunning WT, Exp Lung Res 2000 Dec;26(8):757-72 |
| Lung | Female |
high |
31-32 weeks |
|
Gunning WT, Exp Lung Res 2000 Dec;26(8):757-72 |
| Lung | Male |
55% (11 of 20 mice) |
9.5-10 months |
|
You L, Carcinogenesis 1994 Nov;15(11):2613-8 |
| Lung | Mixed Population |
observed |
|
You M, Carcinogenesis 1992 Sep;13(9):1583-6 | |
| Lung | Female |
observed |
48 weeks |
|
Estensen RD, Carcinogenesis 2004 Feb;25(2):197-201 |
| Lung | Female |
observed |
29-30 weeks |
|
Castonguay A, Exp Lung Res 1998 Jul-Aug;24(4):605-15 |
| Lung | Female |
27% (6 of 22 mice) |
|
Castonguay A, Exp Lung Res 1998 Jul-Aug;24(4):605-15 | |
| Lung | Female |
observed |
|
Castonguay A, Exp Lung Res 1998 Jul-Aug;24(4):605-15 | |
| Lung | Female |
33.33% (6 of 18 mice) |
|
Gordon T, Cancer Lett 2009 Mar 18;275(2):213-20 | |
| Lung | Female |
observed |
|
Gordon T, Cancer Lett 2009 Mar 18;275(2):213-20 | |
| Lung | Unspecified |
observed |
≥1 year |
|
Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 |